Dysbetalipoproteinemia
📧 Sign up to get email alerts when something new happens for Dysbetalipoproteinemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS approval · 2025-10-28Clinical Trial Update: Compassionate Use of Evinacumab
Evinacumab (brand Evkeeza) has gained marketing approval for use in pediatric homozygous familial hypercholesterolemia, as well as indicatio…
-
FDA approval · 2023-03-24FDA Approved: FENOFIBRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for fenofibrate submitted by Mylan Pharmaceuticals Inc., for a generic fenofibrate product.
-
CLINICAL_TRIALS research · 2013-01-28Clinical Trial Update: DARK STUDY "DysbetalipoproteinemiA and atheRoma Risk"
A clinical trial update for the DARK STUDY examining dysbetalipoproteinemia and atheroma risk; current status is unknown.